The report presents a detailed analysis of the Cyclospora diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cyclospora definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Cyclospora tests. Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns. Research Beam Model: Research Beam Product ID: 15436 2800 USD New
Cyclospora Testing Market 2014: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape
 

Cyclospora Testing Market 2014: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape

Cyclospora Testing Market 2014: US, Europe (France, Germany, Italy, Spain, UK), Japan--Emerging Opportunities, Country Forecasts, Innovative Technolog

Category : Diagnostic and Biotech
Published On : January  2014

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

The report presents a detailed analysis of the Cyclospora diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cyclospora definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Cyclospora tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 191 pages and 7 tables



Enquiry Before Buy